T0	Participants 64 87	moderate acne vulgaris.
T1	Participants 323 341	patients with acne
T2	Participants 681 779	Two hundred fifty-seven healthy female subjects, 15 to 49 years of age with moderate acne vulgaris
T3	Participants 1369 1381	160 subjects
T4	Participants 1498 1511	placebo group
T5	Participants 2406 2460	in women with no known contraindication to OC therapy.